GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3801 - 3825 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgG Patient 3 -180 mild
G93351GM
39
IgM Patient 3 -180 mild
G93351GM
74
IgA Patient 3 4 mild
G93351GM
500
IgG Patient 3 11 mild
G93351GM
47
IgG Patient 3 4 mild
G93351GM
49
IgM Patient 3 11 mild
G93351GM
103
IgM Patient 3 4 mild
G93351GM
121
IgA Patient 4 12 mild
G93351GM
372
IgG Patient 4 12 mild
G93351GM
50
IgM Patient 4 12 mild
G93351GM
82
IgA Patient 1 10 moderate
G94435QH
361
IgA Patient 1 22 moderate
G94435QH
364
IgA Patient 1 6 moderate
G94435QH
347
IgG Patient 1 10 moderate
G94435QH
21
IgG Patient 1 22 moderate
G94435QH
22
IgM Patient 1 10 moderate
G94435QH
34
IgM Patient 1 22 moderate
G94435QH
30
IgG Patient 1 6 moderate
G94435QH
26
IgM Patient 1 6 moderate
G94435QH
34
IgA Patient 2 15 mild
G94435QH
285
IgA Patient 2 24 mild
G94435QH
343
IgG Patient 2 15 mild
G94435QH
102
IgG Patient 2 24 mild
G94435QH
115
IgM Patient 2 15 mild
G94435QH
56
IgA Patient 2 3 mild
G94435QH
282

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024